About Sprout Pharmaceuticals
Sprout Pharmaceuticals is a company based in Raleigh (United States) founded in 2011 was acquired by Bausch Health in August 2015.. Sprout Pharmaceuticals has raised $185.16 million across 10 funding rounds from investors including Bausch Health. The company has 31 employees as of December 31, 2015. Sprout Pharmaceuticals offers products and services including Women's Health Products. Sprout Pharmaceuticals operates in a competitive market with competitors including Hope Medicine, Rejoni, ObsEva, Gameto and Forendo Pharma, among others.
- Headquarter Raleigh, United States
- Employees 31 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sprout Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$185.16 M (USD)
in 10 rounds
-
Latest Funding Round
$10.56 M (USD), Series D
Dec 10, 2024
- Investors
-
Employee Count
31
as on Dec 31, 2015
-
Acquired by
Bausch Health
(Aug 20, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sprout Pharmaceuticals
Sprout Pharmaceuticals offers a comprehensive portfolio of products and services, including Women's Health Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Innovative solutions for women's sexual health advancements
Unlock access to complete
Funding Insights of Sprout Pharmaceuticals
Sprout Pharmaceuticals has successfully raised a total of $185.16M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10.56 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $10.6M
-
First Round
First Round
(21 Mar 2012)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series D - Sprout Pharmaceuticals | Valuation |
investors |
|
| Apr, 2023 | Amount | Series D - Sprout Pharmaceuticals | Valuation |
investors |
|
| Aug, 2022 | Amount | Series D - Sprout Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sprout Pharmaceuticals
Sprout Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Bausch Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sprout Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sprout Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sprout Pharmaceuticals Comparisons
Competitors of Sprout Pharmaceuticals
Sprout Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hope Medicine, Rejoni, ObsEva, Gameto and Forendo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for fertility and menopause treatments are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for reproductive health are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sprout Pharmaceuticals
Frequently Asked Questions about Sprout Pharmaceuticals
When was Sprout Pharmaceuticals founded?
Sprout Pharmaceuticals was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is Sprout Pharmaceuticals located?
Sprout Pharmaceuticals is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Is Sprout Pharmaceuticals a funded company?
Sprout Pharmaceuticals is a funded company, having raised a total of $185.16M across 10 funding rounds to date. The company's 1st funding round was a Series D of $27.97M, raised on Mar 21, 2012.
How many employees does Sprout Pharmaceuticals have?
As of Dec 31, 2015, the latest employee count at Sprout Pharmaceuticals is 31.
What does Sprout Pharmaceuticals do?
Sprout Pharmaceuticals was founded in 2011 and is headquartered in Raleigh, United States. Operations focus on the pharmaceutical sector, particularly womens health. An FDA-approved, non-hormonal medication named ADDYI has been developed to address hypoactive sexual desire disorder in premenopausal women. The companys efforts center on drug development for this specific medical condition.
Who are the top competitors of Sprout Pharmaceuticals?
Sprout Pharmaceuticals's top competitors include Rejoni, Hope Medicine and Gameto.
What products or services does Sprout Pharmaceuticals offer?
Sprout Pharmaceuticals offers Women's Health Products.
Who are Sprout Pharmaceuticals's investors?
Sprout Pharmaceuticals has 1 investor. Key investors include Bausch Health.